Session 8: Internationalization of Research: Cures Without Borders
Back to the Agenda |
Wednesday, December 15, 2010
9:15 am - 10:10 am
An expanding research infrastructure outside of the U.S. is not only creating new opportunities for collaboration across the academic community, but also defining fresh new approaches to speeding innovation and development. How is the internationalization of medical research impacting patients, both in the U.S. and globally? Where are the breakthrough models coming from? What are the pros, cons, and next steps? |
| |
| Speakers: |
 |
| • |
Moderator: Solomon Nwaka, Ph.D.
Head of Discovery and Innovation Research Unit
WHO/TDR
|
|
| • |
Rob Califf, M.D.
Vice Chancellor for Clinical Research, Director of the Duke Translational Medicine Institute, and Professor of Medicine in the Division of Cardiology
Duke University Medical Center |
|
| • |
Erez Chimovits, M.B.A., M.Sc.
Managing Director
Israeli Investment Team, OrbiMed |
|
| • |
Sri Mosur
President and CEO of Global Drug Discovery and Development
Jubilant Discovery Solutions, Inc. |
|
|
| |
 |
 |
|
|
Terms Of Use // Privacy Statement
© 2010 by Partnering for Cures |
 |
 |
 |
 |
|
|
